Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2023 Mar 1:2023.02.27.23286534.
doi: 10.1101/2023.02.27.23286534.

Endovascular thrombectomy for the treatment of large ischemic stroke: a systematic review and meta-analysis of randomized control trials

Travis J Atchley  1 , Dagoberto Estevez-Ordonez  1 , Nicholas M B Laskay  1 , Borna E Tabibian  1 , Mark R Harrigan  1
Affiliations

Endovascular thrombectomy for the treatment of large ischemic stroke: a systematic review and meta-analysis of randomized control trials

Travis J Atchley et al. medRxiv. .

Update in

Abstract

Importance: Endovascular thrombectomy (ET) has previously been reserved for patients with small to medium acute ischemic strokes. Three recent randomized control trials (RCTs) have demonstrated functional benefit and risk profiles for ET in large volume ischemic strokes.

Objective: The primary objective of the meta-analysis was to determine the combined benefit of ET in adult patients with large volume acute ischemic strokes and to better determine the risk of adverse events following ET.

Data sources: We systematically searched MEDLINE, EMBASE, SCOPUS, the Cochrane Central Register of Controlled, and Google Scholar for all RCTs published in English language between January 1, 2010, to February 19, 2023.

Study selection: We included only RCTs specifically comparing ET to medical therapy in patients with acute ischemic stroke with large volume infarctions as defined by Alberta Stroke Program Early Computed Tomography Score (ASPECTS) 3-5 or calculated infarct volume of > 50-70mL. Two independent reviewers screened potential studies for full text review and metaanalysis inclusion with conflicts being resolved by consensus or third reviewer.

Data extraction and synthesis: Data was extracted based on pre-specified variables on study methods and design, participant characteristics, analysis approach, as well as efficacy and safety outcomes. Results were combined using a restricted maximum-likelihood estimation random-effects model. Studies were assessed for potential bias and quality of evidence.

Main outcomes and measures: The prespecified primary outcome was an overall ordinal shift across the range of modified Rankin scale scores toward a better outcome at 90 days following either ET or medical management for patients with large volume ischemic strokes.

Results: A total of 3044 studies were screened, and 29 underwent full text review. 3 RCTs (1011 patients) were included in the analysis. The pooled random effects model for the primary outcome of mRS improvement favored ET over medical management, generalized odds ratio 1.55 [95% CI 1.25 - 1.91, T 2 = 0.01, I 2 = 42.84%]. There was a trend toward increased risk of symptomatic ICH in the ET group, relative risk 1.85 [95% CI 0.94 - 3.63, T 2 = 0.00, I 2 = 0.00%].

Conclusions and relevance: In patients with large volume ischemic strokes, ET has a clear functional benefit and does not confer increased risk of significant complications compared to medical management alone.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

On behalf of all authors, there are no conflicts of interest.

Figures

Figure 1.
Figure 1.
PRISMA Flow Diagram for Study Screening and Inclusion/Exclusion
Figure 2.
Figure 2.
Forest plots for random-effects models for primary and secondary outcomes. CI = confidence interval; HC = hemicraniectomy; mRS = modified Ranking scale; REML = restricted maximum likelihood.
Figure 2.
Figure 2.
Forest plots for random-effects models for primary and secondary outcomes. CI = confidence interval; HC = hemicraniectomy; mRS = modified Ranking scale; REML = restricted maximum likelihood.
Figure 3.
Figure 3.
Subgroup analysis forest plots of random effects models. ASPECTS = Albert Stroke Program Early Computed Tomography Score; CI = confidence interval; ICA = internal carotid artery; MCA = middle cerebral artery; mL = milliliters; REML = restricted maximum likelihood.
See this image and copyright information in PMC

References

    1. Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018;378(1):11–21. doi: 10.1056/NEJMoa1706442 - DOI - PubMed
    1. Albers GW, Marks MP, Kemp S, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018;378(8):708–718. doi: 10.1056/NEJMoa1713973 - DOI - PMC - PubMed
    1. Berkhemer OA, Fransen PSS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11–20. doi: 10.1056/NEJMoa1411587 - DOI - PubMed
    1. Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372(24):2285–2295. doi: 10.1056/NEJMoa1415061 - DOI - PubMed
    1. Pirson FAVA Hinsenveld WH, Goldhoorn RJB, et al. MR CLEAN-LATE, a multicenter randomized clinical trial of endovascular treatment of acute ischemic stroke in The Netherlands for late arrivals: study protocol for a randomized controlled trial. Trials. 2021;22(1):160. doi: 10.1186/s13063-021-05092-0 - DOI - PMC - PubMed

Publication types